2022/12/02
The 7th International Congress of biopharmaceuticals Committee has interviewed in advance Innoforce pharmaceuticals’ CEO, Dr. Yuling Li, to give us seasoned experience on Risk Assessment and Risk Management for Biopharmaceutical Development.
Please scan the 2D code for more details
